Medical Oncology Hematology Consultants Helen F Graham Cancer Center is a clinical research site located in Newark, Delaware, United States 19713.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
Medical Oncology Hematology Consultants Helen F Graham Cancer Center has participated in 5 clinical trials with 4 currently active.
Therapeutic areas: Metastatic Castration-resistant Prostate Cancer, Melanoma, KRAS p.G12C Mutant Advanced Solid Tumors.
Sponsors: Amgen.
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Medical Oncology Hematology Consultants Helen F Graham Cancer Center has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Medical Oncology Hematology Consultants Helen F Graham Cancer Center has 5 clinical trials on record, with 4 currently active. Their work covers Metastatic Castration-resistant Prostate Cancer, Melanoma, KRAS p.G12C Mutant Advanced Solid Tumors.
Medical Oncology Hematology Consultants Helen F Graham Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.